Repeat implantable cardioverter defibrillator (ICD) procedures are increasing and may be associated with higher risks for complications. To provide more information for clinical decision making, especially in light of recent defibrillator advisories, we examined a large national cohort to characterize repeat ICD procedural outcomes. Using data from the National Cardiovascular Data Registry (ICD Registry), we compared patient characteristics, reasons for ICD implantation, and associated in-hospital adverse events among 92,751 patients receiving their first device and 81,748 patients who underwent repeat procedures with (n = 31,057) and without (n = 50,691) lead involvement. Hierarchical multivariable logistic regression was used to determine the predictors of in-hospital complications. Complication rates were higher in those who underwent repeat ICD procedures with lead involvement (lead implantation or revision), compared with patients who underwent initial implants (3.2% vs 2.6%, p <0.001) or versus those with pocket-only (e.g., generator change only) procedures (3.2% vs 0.6%, p <0.001). There were significantly more in-hospital deaths, lead dislodgements, and infections requiring antibiotics in the lead involvement cohort. Compared with those who had a pocket-only procedure, the multivariable adjusted odds ratio of any complication were increased at 4.20 (95% confidence interval: 3.66 to 4.82, p <0.001) in patients who underwent repeat procedures with lead involvement excluding lead extraction or 7.11 (95% confidence interval: 5.96 to 8.48, p <0.001) in procedures involving lead extractions. In conclusion, repeat ICD procedures, when involving the addition or revision of a lead with or without concurrent lead extraction, are associated with higher complication rates compared with initial implants and with those who underwent pocket-only procedures.
There are few studies comparing the complication rates specifically related to the indication for a repeat implantable cardioverter defibrillator (ICD) procedure. The implantable cardiac pulse generator replacement registry (REPLACE) reported a difference in complication rates between patients who underwent repeat pocket procedures with and without lead implantation or revision. Furthermore, studies examining lead revision and extraction outcomes because of lead advisory recalls have found an increased rate of procedure-related complications. It is important for both patients and implanting physicians to be aware of the causes of device reimplantation and their potential adverse effects. The National Cardiovascular Data Registry (NCDR) offers an opportunity to study the causes and complications of repeat ICD procedures across a large population. This study seeks to define the characteristics of patients who underwent ICD reimplantation procedures, the distribution of specific indications for reimplantation, and important predictors of in-hospital complications.
Methods
Data and cross-sectional analyses were provided by the NCDR ICD Registry. Participating hospitals are required to submit periprocedural data on all Medicare patients receiving primary prevention devices. In addition, >80% of hospitals in the United States routinely submit standardized data on all patients. All procedures performed between April 1, 2010 and June 30, 2011 including single-chamber, dual-chamber, and cardiac resynchronization therapy (CRT) ICDs were screened for patients who underwent reimplant procedures. Patients requiring a thoracotomy were excluded.
Three separate groups consisting of patients who underwent initial ICD implant, repeat procedures with lead revision or replacement, and generator replacement only were analyzed. Initial implants consisted of procedures in patients with no previous pacemaker or ICD. A reoperation procedure with lead implantation or revision consisted of any reoperation procedure involving the implantation of a new lead, such as an upgrade from a previous pacemaker to an ICD requiring a defibrillation lead; upgrade of an ICD to a dual chamber ICD or CRT defibrillator; lead replacement or revision with or without lead extraction; device infection in which the leads are manipulated or replaced; or a malfunction because of a problem with atrial pacing, right ventricular pacing, left ventricular pacing, or lead-related defibrillation function. A reoperation with pocket-only procedure was defined as any reoperation procedure without involvement of a lead, such as a generator change only, a pocket revision, or a procedure to move the generator.
The primary outcome was in-hospital major adverse event during and after device procedure until the end of the hospital stay. These events included cardiac arrest, cardiac perforation, cardiac valve injury, conduction block, hematoma requiring reoperation, evacuation or transfusion, hemothorax, lead dislodgement, myocardial infarction, pericardial tamponade, set screw problem, pneumothorax, transient ischemic attack or stroke, urgent cardiac surgery, drug reaction, coronary venous dissection, infection requiring antibiotics, peripheral embolus, peripheral nerve injury, and venous obstruction. All complications occurred during the hospital stay for the given ICD procedure. Patients could have >1 complication recorded; multiple complications were not considered separately.
Statistical analyses were performed at the NCDR Analysis Center at Yale University. Baseline patient characteristics were compared using independent t tests, analysis of variance, and chi-square tests. Wilcoxon rank sum tests and Kruskal-Wallis tests were used when normality assumptions of continuous variables were violated. Tests comparing characteristics of patients who underwent reimplantation procedures and initial ICD implantation were also performed. Total number of in-hospital complications associated with reimplantation was tabulated according to the subgroups categorized based on the reason for ICD procedure, and simple proportions were calculated. To examine potential predictors of in-hospital complications in patients who underwent reimplantation, univariate hierarchical logistic regression models based on the baseline patient variables adjusting for clustering on center were first fitted. A similar multivariable hierarchical logistic regression model adjusting for clustering was developed by including all variables significant at the univariate level. Each variable was evaluated for significance and confounding. Variables no longer significantly contributing to the overall model and that did not produce confounding of other variables were dropped from the model. Variables having the highest p-values were evaluated first, and this step was performed iteratively until all variables in the model met the inclusion criteria of p <0.05. Before modeling, categorical variable missing data were assumed to represent a “no” response. Continuous variable missing data were imputed with the median. SAS v9.2 was used for the analyses (SAS Institute, Cary, N C).
Results
Our analysis included 174,499 patient hospital visits. This included 92,751 initial ICD implants, 31,057 patients who underwent repeat procedures involving lead revision or replacement, and 50,691 patients who underwent generator-only procedures. A comparison of patient characteristics between patients with initial ICD implantation, repeat procedures involving lead replacement or revision, and repeat procedures involving the generator only are listed in Table 1 . Compared with new ICD implants, patients who underwent repeat procedures were older and more likely to be men; they had more atrial and ventricular arrhythmias and were more likely to have dual chamber or CRT devices with underlying paced cardiac rhythms. Compared with those who had pocket-only procedures, those who underwent repeat procedures involving lead implantation or revision had more heart failure with a lower ejection fraction, valvular heart disease, atrial arrhythmias, and cardiovascular co-morbidities.
Description | Implant Status | p-Values | |||
---|---|---|---|---|---|
Initial Implant | Reoperation With Lead Involvement | Repeat Pocket Procedure | Initial vs All Repeat Procedures | Reoperation With Lead Involvement vs Pocket-Only Procedure | |
n = 92751 | n = 31057 | n = 50691 | |||
Age >70 years | 34598 (37.3%) | 16509 (53.2%) | 27232 (53.7%) | <0.001 | 0.116 |
Female | 26327 (28.4%) | 7608 (24.5%) | 13633 (26.9%) | <0.001 | <0.001 |
White | 75953 (81.9%) | 27284 (87.9%) | 44905 (88.6%) | <0.001 | 0.002 |
Heart failure | 72193 (77.8%) | 26377 (84.9%) | 38889 (76.7%) | <0.001 | <0.001 |
NYHA functional classification | <0.001 | <0.001 | |||
I | 13356 (14.4%) | 3632 (11.7%) | 10850 (21.4%) | ||
II | 32676 (35.2%) | 8013 (25.8%) | 20896 (41.2%) | ||
III | 43305 (46.7%) | 18136 (58.4%) | 17769 (35.1%) | ||
IV | 3046 (3.3%) | 1160 (3.7%) | 914 (1.8%) | ||
Nonischemic cardiomyopathy | 32854 (35.4%) | 10402 (33.5%) | 15323 (30.2%) | <0.001 | <0.001 |
Coronary heart disease | 55900 (60.3%) | 19684 (63.4%) | 32793 (64.7%) | <0.001 | <0.001 |
Prior myocardial infarction | 45866 (49.5%) | 15507 (49.9%) | 26692 (52.7%) | <0.001 | <0.001 |
Prior percutaneous coronary intervention | 30071 (32.4%) | 10115 (32.6%) | 16310 (32.2%) | 0.679 | 0.215 |
Prior coronary bypass | 27346 (29.5%) | 11536 (37.1%) | 18718 (36.9%) | <0.001 | 0.512 |
Primary valvular heart disease | 10712 (11.6%) | 4899 (15.8%) | 5735 (11.3%) | <0.001 | <0.001 |
Cerebrovascular disease | 13822 (14.9%) | 5481 (17.7%) | 8392 (16.6%) | <0.001 | <0.001 |
Chronic lung disease | 20228 (21.8%) | 6926 (22.3%) | 10404 (20.5%) | 0.002 | <0.001 |
Diabetes mellitus | 35692 (38.5%) | 11924 (38.4%) | 18241 (36.0%) | <0.001 | <0.001 |
Sleep apnea | 10540 (11.4%) | 4176 (13.5%) | 5854 (11.6%) | <0.001 | <0.001 |
Dialysis | 3018 (3.2%) | 734 (2.4%) | 1022 (2.0%) | <0.001 | <0.001 |
Hypertension | 73027 (78.7%) | 24274 (78.2%) | 38809 (76.6%) | <0.001 | <0.001 |
Syncope | 15318 (16.5%) | 5232 (16.9%) | 7644 (15.1%) | <0.001 | <0.001 |
Family history of sudden death | 3749 (4.0%) | 1087 (3.5%) | 1891 (3.7%) | <0.001 | 0.089 |
Atrial fibrillation/flutter | 26575 (28.7%) | 15330 (49.4%) | 20608 (40.7%) | <0.001 | <0.001 |
Ventricular tachycardia | 28922 (31.2%) | 13730 (44.2%) | 24457 (48.3%) | <0.001 | <0.001 |
Cardiac arrest | 9939 (10.7%) | 3176 (10.2%) | 5578 (11.0%) | 0.978 | <0.001 |
Previous implantable cardioverter defibrillator | 0 | 20180 (65.0%) | 50691 (100.0%) | <0.001 | <0.001 |
Permanent pacemaker | 0 | 13151 (42.3%) | 6185 (12.2%) | <0.001 | <0.001 |
Implantable cardioverter defibrillator indication | <0.001 | ||||
Primary prevention | 74657 (80.5%) | 22820 (73.5%) | 36124 (71.3%) | <0.001 | <0.001 |
Secondary prevention | 18094 (19.5%) | 8237 (26.5%) | 14567 (28.7%) | <0.001 | <0.001 |
Final device type | <0.001 | <0.001 | |||
Single chamber | 21779 (23.5%) | 2497 (8.0%) | 8340 (16.5%) | ||
Dual chamber | 40026 (43.2%) | 8202 (26.4%) | 20015 (39.5%) | ||
Cardiac resynchronization therapy defibrillator | 30725 (33.1%) | 20320 (65.4%) | 22241 (43.9%) | ||
Left ventricular ejection fraction | <0.001 | <0.001 | |||
≤30% | 65550 (70.7%) | 19329 (62.2%) | 20081 (39.6%) | ||
31%–40% | 15731 (17.0%) | 5363 (17.3%) | 8481 (16.7%) | ||
>40% | 9982 (10.8%) | 3692 (11.9%) | 11290 (22.3%) | ||
QRS duration—121–140 ms | 13469 (14.5%) | 3273 (10.5%) | 4290 (8.5%) | <0.001 | <0.001 |
Cardiac rhythm—paced | 1185 (1.3%) | 16007 (51.5%) | 27107 (53.5%) | <0.001 | <0.001 |
Abnormal intraventricular conduction | 45124 (48.7%) | 20531 (66.1%) | 27190 (53.6%) | <0.001 | <0.001 |
Left bundle branch block | 23341 (25.2%) | 7583 (24.5%) | 8216 (16.3%) | <0.001 | <0.001 |
Right bundle branch block | 9576 (10.4%) | 2685 (8.7%) | 3456 (6.9%) | <0.001 | <0.001 |
Left anterior fascicular block | 4640 (5.0%) | 978 (3.2%) | 1304 (2.6%) | <0.001 | <0.001 |
Left posterior fascicular block | 789 (0.85%) | 192 (0.6%) | 252 (0.5%) | <0.001 | <0.001 |
Ventricular paced rhythm | 516 (0.6%) | 8554 (27.7%) | 13321 (26.4%) | <0.001 | <0.001 |
Systolic blood pressure <100 mm Hg | 5040 (5.4%) | 1943 (6.3%) | 2305 (4.6%) | 0.028 | <0.001 |
Creatinine >2.0 mg/dl | 7281 (7.9%) | 2767 (8.9%) | 3677 (7.3%) | 0.418 | <0.001 |
Mean BNP (pg/ml) | 992.4 | 946.3 | 593 | <0.001 | <0.001 |
Aldosterone receptor blocker or angiotensin-converting enzyme use | 69668 (75.1%) | 21806 (70.2%) | 34813 (68.7%) | <0.001 | <0.001 |
Antiarrhythmic use | 14282 (15.4%) | 7926 (25.5%) | 11153 (22.0%) | <0.001 | <0.001 |
Beta blocker use | 81472 (87.8%) | 26920 (86.7%) | 43085 (85.0%) | <0.001 | <0.001 |
Statin use | 60918 (65.7%) | 20530 (66.1%) | 33879 (66.8%) | <0.001 | <0.001 |
Device manufacturer | <0.001 | <0.001 | |||
Biotronik | 4695 (5.1%) | 1019 (3.3%) | 1192 (2.4%) | ||
Boston Scientific | 20576 (22.2%) | 6376 (20.5%) | 15853 (31.3%) | ||
Cameron health | 169 (0.2%) | 19 (0.1%) | 2 (0.0%) | ||
ELA medical | 506 (0.6%) | 112 (0.4%) | 109 (0.2%) | ||
Guidant | 328 (0.4%) | 85 (0.3%) | 494 (1.0%) | ||
Medtronic | 38873 (41.9%) | 16128 (51.9%) | 23987 (47.3%) | ||
St Jude medical | 27604 (29.8%) | 7318 (23.6%) | 9054 (17.9%) | ||
No specialized electrophysiology training | 5970 (6.4%) | 1602 (5.2%) | 3009 (5.9%) | <0.001 | <0.001 |
End of expected battery life was the major reason for reimplantation in the pocket-only cohort (95.7%), compared with 28.1% in the lead implantation or revision cohort ( Table 2 ). Thirty-five percentage of the lead-related reimplant group was referred for an upgrade from a pacemaker to an ICD. Other reasons for a reimplantation with lead involvement included lead dislodgement or other reasons for lead revision (12.9%), infection (5.5%), device malfunction (3.2%), and advisory or recall (1.6%).
Reasons for Reimplantation | Reoperation With Lead Involvement | Pocket Procedure | p-Values |
---|---|---|---|
n = 31057 | n = 50691 | ||
Upgrade from pacemaker to implantable cardioverter defibrillator | 10879 (35.0%) | 0 | <0.001 |
End of expected battery life | 8715 (28.1%) | 48502 (95.7%) | <0.001 |
Replaced at time of lead revision | 3995 (12.9%) | 635 (1.3%) | <0.001 |
Any implantable cardioverter defibrillator upgrade | 9853 (31.7%) | 1546 (3.1%) | <0.001 |
Infection | 1701 (5.5%) | 181 (0.4%) | <0.001 |
Under manufacturer advisory/recall | 490 (1.6%) | 297 (0.6%) | <0.001 |
Faulty connector/header | 93 (0.3%) | 66 (0.1%) | <0.001 |
Device relocation | 334 (1.1%) | 214 (0.4%) | <0.001 |
Malfunction | 990 (3.2%) | 495 (1.0%) | <0.001 |
The incidence of adverse events in those patients who underwent initial ICD implantation was 2.6%. Overall, adverse event rates were significantly higher in patients who underwent reimplantation with lead manipulation (3.2%), compared with those with pocket-only procedures (0.6%) and initial implantation. There were significantly more patient deaths, cardiac events, hematomas, lead dislodgements, pneumothoraces, infections, and venous issues in the reimplant cohort with lead involvement compared with those without lead involvement and with initial implants ( Table 3 and Figure 1 ). Complications with pocket-only reimplantation procedures were significantly lower compared with reimplant procedures requiring a lead implantation or revision and compared with initial ICD implants. For every 100 patients who underwent lead reimplantation or revision instead of a pocket-only procedure, there would be an increase of 2.6 major adverse events.
Complication | Initial Implant | Reoperation With Lead Involvement | Pocket Procedure | p-Value | |
---|---|---|---|---|---|
n = 92571 | n = 31057 | n = 50691 | Initial vs All Repeat Procedures | Reoperation With Lead Involvement vs Pocket-Only Procedure | |
All events | 2382 (2.6%) | 994 (3.2%) | 302 (0.6%) | <0.001 | <0.001 |
Discharge status—dead | 318 (0.34%) | 109 (0.35%) | 52 (0.1%) | <0.001 | <0.001 |
Cardiac arrest | 243 (0.26%) | 83 (0.27%) | 40 (0.08%) | <0.001 | <0.001 |
Cardiac perforation | 67 (0.07%) | 22 (0.07%) | 2 (0.0%) | <0.001 | <0.001 |
Cardiac valve injury | 1 (0.0%) | 0 | 0 | NA | NA |
Conduction block | 38 (0.04%) | 5 (0.02%) | 1 (0.0%) | <0.001 | 0.032 |
Hematoma requiring reoperation, evacuation or transfusion | 264 (0.28%) | 201 (0.65%) | 86 (0.17%) | 0.014 | <0.001 |
Hemothorax | 24 (0.03%) | 21 (0.07%) | 5 (0.01%) | 0.465 | <0.001 |
Lead dislodgement | 869 (0.94%) | 349 (1.12%) | 29 (0.06%) | <0.001 | <0.001 |
Myocardial infarction | 27 (0.03%) | 4 (0.01%) | 2 (0.0%) | 0.001 | 0.209 |
Pericardial tamponade | 92 (0.1%) | 22 (0.07%) | 2 (0.0%) | <0.001 | <0.001 |
Set screw problem | 33 (0.04%) | 17 (0.05%) | 5 (0.01%) | 0.309 | <0.001 |
Pneumothorax | 299 (0.32%) | 112 (0.36%) | 27 (0.05%) | <0.001 | <0.001 |
Transient ischemic attack or stroke | 47 (0.05%) | 22 (0.07%) | 7 (0.01%) | 0.129 | <0.001 |
Urgent cardiac surgery | 22 (0.02%) | 5 (0.02%) | 2 (0.0%) | 0.014 | 0.113 |
Drug reaction | 55 (0.06%) | 19 (0.06%) | 17 (0.03%) | 0.164 | 0.068 |
Coronary venous dissection | 128 (0.14%) | 42 (0.14%) | 11 (0.02%) | <0.001 | <0.001 |
Infection requiring antibiotics | 85 (0.09%) | 44 (0.14%) | 16 (0.03%) | 0.187 | <0.001 |
Peripheral embolus | 12 (0.01%) | 10 (0.03%) | 0 | <0.001 | <0.001 |
Peripheral nerve injury | 1 (0.0%) | 1 (0.0%) | 1 (0.0%) | NA | NA |
Venous obstruction | 25 (0.03%) | 28 (0.09%) | 8 (0.02%) | 0.057 | <0.001 |